Understanding Prognosis: Discrepancy in Prognosis Estimates Between Patients With Cirrhosis and their Hepatologists.


Journal

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775

Informations de publication

Date de publication:
04 2023
Historique:
received: 07 01 2022
revised: 28 03 2022
accepted: 26 04 2022
pmc-release: 01 04 2024
pubmed: 2 6 2022
medline: 28 3 2023
entrez: 1 6 2022
Statut: ppublish

Résumé

Patients require a clear understanding of their prognosis to make informed decisions about their care. The aim of this study was to compare the perceptions of prognosis and transplant candidacy between patients with cirrhosis and their hepatologists. Patients with cirrhosis and their hepatologists were prospectively recruited at an urban liver transplant center. Patients and hepatologists were asked about transplant candidacy and about how many years patients would live with and without a liver transplant. Agreement between patients and hepatologists was assessed with the weighted kappa statistic. Associations between patient/hepatologists' prognostic estimates and those predicted by patients' Model for End-Stage Liver Disease-Sodium (MELD-Na) score were estimated using the Pearson correlation coefficient. Seventy patients and 6 hepatologists were enrolled in the study. Patients were predominantly male (61.4%) and white (68.6%), with a mean MELD-Na score of 19 ± 9. There was no-slight agreement between patients and hepatologists regarding survival without and with a liver transplant (κ = 0.1 and 0.2, respectively), with patients more optimistic than their hepatologists. There was greater agreement between patients and hepatologists about transplant candidacy (κ = 0.6). There was a negligible association between MELD-Na and patient estimates (r = -0.24, P = .05) but a moderate association between MELD-Na and hepatologist estimates (r = -0.51, P < .001), with higher MELD-Na scores associated with lower predicted survival. Patients with cirrhosis are more optimistic and less accurate in their predictions of survival compared with hepatologists, although they are more realistic about their transplant candidacy. Aligning patient and provider expectations may increase the likelihood that patients receive value-concordant care.

Sections du résumé

BACKGROUND & AIMS
Patients require a clear understanding of their prognosis to make informed decisions about their care. The aim of this study was to compare the perceptions of prognosis and transplant candidacy between patients with cirrhosis and their hepatologists.
METHODS
Patients with cirrhosis and their hepatologists were prospectively recruited at an urban liver transplant center. Patients and hepatologists were asked about transplant candidacy and about how many years patients would live with and without a liver transplant. Agreement between patients and hepatologists was assessed with the weighted kappa statistic. Associations between patient/hepatologists' prognostic estimates and those predicted by patients' Model for End-Stage Liver Disease-Sodium (MELD-Na) score were estimated using the Pearson correlation coefficient.
RESULTS
Seventy patients and 6 hepatologists were enrolled in the study. Patients were predominantly male (61.4%) and white (68.6%), with a mean MELD-Na score of 19 ± 9. There was no-slight agreement between patients and hepatologists regarding survival without and with a liver transplant (κ = 0.1 and 0.2, respectively), with patients more optimistic than their hepatologists. There was greater agreement between patients and hepatologists about transplant candidacy (κ = 0.6). There was a negligible association between MELD-Na and patient estimates (r = -0.24, P = .05) but a moderate association between MELD-Na and hepatologist estimates (r = -0.51, P < .001), with higher MELD-Na scores associated with lower predicted survival.
CONCLUSIONS
Patients with cirrhosis are more optimistic and less accurate in their predictions of survival compared with hepatologists, although they are more realistic about their transplant candidacy. Aligning patient and provider expectations may increase the likelihood that patients receive value-concordant care.

Identifiants

pubmed: 35643416
pii: S1542-3565(22)00515-8
doi: 10.1016/j.cgh.2022.04.042
pmc: PMC9699897
mid: NIHMS1811009
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1005-1012.e4

Subventions

Organisme : NINR NIH HHS
ID : R21 NR018693
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002384
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 AGA Institute. Published by Elsevier Inc. All rights reserved.

Références

J Pain Symptom Manage. 2022 Feb;63(2):e212-e223
pubmed: 34508816
JAMA Intern Med. 2021 Jul 1;181(7):949-959
pubmed: 34028505
J Pain Symptom Manage. 2020 Mar;59(3):590-598
pubmed: 31655192
J Clin Oncol. 2010 Mar 1;28(7):1203-8
pubmed: 20124172
Gut. 1999 Aug;45(2):295-300
pubmed: 10403745
Liver Transpl. 2019 Jun;25(6):859-869
pubmed: 30963669
JAMA. 1998 Jun 3;279(21):1709-14
pubmed: 9624023
J Hepatol. 2004 Jun;40(6):897-903
pubmed: 15158328
JAMA Intern Med. 2013 Jul 8;173(13):1206-14
pubmed: 23712681
Am J Transplant. 2016 Oct;16(10):2903-2911
pubmed: 27062327
JAMA. 2021 Oct 5;326(13):1259-1260
pubmed: 34529011
BMJ. 2000 Feb 19;320(7233):469-72
pubmed: 10678857
J Palliat Med. 2020 Apr;23(4):552-557
pubmed: 31618102
Hepatology. 2013 Sep;58(3):1122-32
pubmed: 23389962
JAMA. 2019 Oct 8;322(14):1345-1346
pubmed: 31415085
JAMA Surg. 2017 Jun 1;152(6):531-538
pubmed: 28146230
J Am Geriatr Soc. 2000 May;48(S1):S122-30
pubmed: 10809465
Dig Dis Sci. 2021 May;66(5):1446-1451
pubmed: 32500286
Arch Intern Med. 2009 Mar 9;169(5):480-8
pubmed: 19273778
J Pain Symptom Manage. 2017 May;53(5):821-832.e1
pubmed: 28062339
Hepatology. 2000 Apr;31(4):864-71
pubmed: 10733541
JAMA Intern Med. 2021 May 1;181(5):652-660
pubmed: 33720273
J Pain Symptom Manage. 2021 Jul;62(1):10-19.e4
pubmed: 33253786
J Palliat Med. 2021 May;24(5):719-724
pubmed: 32996824

Auteurs

Alyson Kaplan (A)

Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell School of Medicine, New York Presbyterian, New York, New York.

Lauren Comisar (L)

Weill Cornell Medical College, Weill Cornell Medicine, New York, New York.

Nneka N Ufere (NN)

Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Deanna Jannat-Khah (D)

Weill Cornell Medical College, Weill Cornell Medicine, New York, New York.

Russell Rosenblatt (R)

Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell School of Medicine, New York Presbyterian, New York, New York.

Brett Fortune (B)

Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell School of Medicine, New York Presbyterian, New York, New York.

Holly G Prigerson (HG)

Weill Cornell Medical College, Weill Cornell Medicine, New York, New York.

Robert Brown (R)

Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell School of Medicine, New York Presbyterian, New York, New York. Electronic address: rsb2005@med.cornell.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH